Renowned Korean entertainment couple Bae Da-hye and Lee Jang-won recently announced that they are undergoing a second IVF treatment, hoping to welcome a second child. The couple successfully had their first child through IVF as early as 2022, and their choice to once again use assisted reproductive technology has drawn public attention to IVF treatment. IVF (in vitro fertilization) is the most common assisted reproductive technology worldwide and is suitable for various infertility situations, including fallopian tube blockage, male factor infertility, ovulation disorders, and others. The treatment is usually divided into several stages: first, ovarian stimulation is performed, using medication to stimulate the ovaries to produce multiple eggs; then, under ultrasound guidance, an egg retrieval procedure is performed to obtain mature eggs; next, sperm and eggs are combined in the laboratory to form embryos; finally, high-quality embryos are selected for transfer into the uterus, and a pregnancy test is done two weeks later.
For couples like Bae Da-hye and her husband who have previously successfully had a child through IVF, the success rate of undergoing the treatment again is usually higher, because they have already demonstrated that their reproductive systems respond well to IVF. However, the success rate is still affected by multiple factors, such as the woman's age, ovarian function (such as AMH levels), embryo quality, and endometrial condition. Age is a key factor, because as age increases, egg quantity and quality decline, leading to a higher rate of chromosomal abnormalities in embryos. Therefore, even for couples who have previously successfully had a child, before undergoing a second treatment, a comprehensive fertility assessment is still needed, including hormone tests, ultrasound examinations, and semen analysis, in order to formulate a personalized treatment plan.
For Chinese-speaking readers planning cross-border medical care, several important points should be noted when choosing overseas IVF treatment. First, regulations on assisted reproductive technology vary greatly among countries; for example, the permitted scope of embryo screening (such as PGT), the time limit for embryo cryopreservation, and regulations on embryo donation may all affect the course of treatment. Second, the technical standard of a medical institution's laboratory is crucial, including blastocyst culture capability, embryo freezing techniques (such as vitrification), and the accuracy of genetic testing, all of which directly affect the success rate. In addition, treatment costs and insurance coverage are also important considerations; costs can differ severalfold among different countries, and most insurance does not cover overseas treatment, so a budget must be planned in advance.
Readers are advised that before deciding on overseas IVF, they should first consult a professional reproductive medicine center, undergo a comprehensive fertility assessment, and understand local legal regulations on embryo handling. At the same time, they can communicate with overseas medical institutions through teleconsultation, confirm their technical certifications and success rate data, and request detailed cost breakdowns. In addition, logistical arrangements such as accommodation, transportation, and translation during the treatment period should be considered to ensure the entire process goes smoothly. Through adequate preparation and information gathering, cross-border patients can undergo IVF treatment with greater peace of mind and improve their chances of success.
Source: Chosunbiz. This article is a compiled report and is for general informational reference only.
This article was prepared with AI assistance and reviewed by our editorial team before publication.
This content is for informational purposes only and does not constitute medical advice. Please consult a licensed physician. Content guidelines & editorial policy
News | South Korean celebrity couple tries IVF again, hoping for a second child
Renowned Korean entertainment couple Bae Da-hye and Lee Jang-won recently announced that they are undergoing a second IVF treatment, hoping to welcome a second child. The couple successfully had their first child through IVF as early as 2022, and their choice to once again use assisted reproductive technology has drawn public attention to IVF treatment. IVF (in vitro fertilization) is the most common assisted reproductive technology worldwide and is suitable for various infertility situations, including fallopian tube blockage, male factor infertility, ovulation disorders, and others. The treatment is usually divided into several stages: first, ovarian stimulation is performed, using medication to stimulate the ovaries to produce multiple eggs; then, under ultrasound guidance, an egg retrieval procedure is performed to obtain mature eggs; next, sperm and eggs are combined in the laboratory to form embryos; finally, high-quality embryos are selected for transfer into the uterus, and a pregnancy test is done two weeks later.
For couples like Bae Da-hye and her husband who have previously successfully had a child through IVF, the success rate of undergoing the treatment again is usually higher, because they have already demonstrated that their reproductive systems respond well to IVF. However, the success rate is still affected by multiple factors, such as the woman's age, ovarian function (such as AMH levels), embryo quality, and endometrial condition. Age is a key factor, because as age increases, egg quantity and quality decline, leading to a higher rate of chromosomal abnormalities in embryos. Therefore, even for couples who have previously successfully had a child, before undergoing a second treatment, a comprehensive fertility assessment is still needed, including hormone tests, ultrasound examinations, and semen analysis, in order to formulate a personalized treatment plan.
For Chinese-speaking readers planning cross-border medical care, several important points should be noted when choosing overseas IVF treatment. First, regulations on assisted reproductive technology vary greatly among countries; for example, the permitted scope of embryo screening (such as PGT), the time limit for embryo cryopreservation, and regulations on embryo donation may all affect the course of treatment. Second, the technical standard of a medical institution's laboratory is crucial, including blastocyst culture capability, embryo freezing techniques (such as vitrification), and the accuracy of genetic testing, all of which directly affect the success rate. In addition, treatment costs and insurance coverage are also important considerations; costs can differ severalfold among different countries, and most insurance does not cover overseas treatment, so a budget must be planned in advance.
Readers are advised that before deciding on overseas IVF, they should first consult a professional reproductive medicine center, undergo a comprehensive fertility assessment, and understand local legal regulations on embryo handling. At the same time, they can communicate with overseas medical institutions through teleconsultation, confirm their technical certifications and success rate data, and request detailed cost breakdowns. In addition, logistical arrangements such as accommodation, transportation, and translation during the treatment period should be considered to ensure the entire process goes smoothly. Through adequate preparation and information gathering, cross-border patients can undergo IVF treatment with greater peace of mind and improve their chances of success.
Source: Chosunbiz. This article is a compiled report and is for general informational reference only.